Steroid-eluting stents in patients with acute coronary syndrome: the Dexamethasone Eluting Stent Italian REgistry
暂无分享,去创建一个
F. Piscione | C. Vassanelli | F. Tomai | V. Ferrero | E. Verna | R. Pirisi | C. Tamburino | N. D. De Cesare | F. Ribichini | G. Di Sciascio | M. Romano | M. Galli | L. Paloscia | G. Carosio | G. Lanteri
[1] F. Eberli,et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. , 2005, The New England journal of medicine.
[2] F. Crea,et al. Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD study. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[3] G. Stone,et al. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial. , 2005, Journal of the American College of Cardiology.
[4] R. Blindt,et al. Evaluation of a high-dose dexamethasone-eluting stent. , 2004, The American journal of cardiology.
[5] J. W. Schaeffer,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article , 2002 .
[6] Carl J Pepine,et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.